iBio, Inc.
IBIO
$1.25
-$0.02-1.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -33.04M | -27.61M | -24.74M | -20.11M | -18.38M |
| Total Depreciation and Amortization | 1.03M | 1.07M | 1.10M | 1.14M | 1.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.27M | 6.06M | 3.63M | 1.37M | 1.47M |
| Change in Net Operating Assets | 2.52M | -1.12M | 1.39M | 350.00K | 479.00K |
| Cash from Operations | -23.22M | -21.61M | -18.63M | -17.25M | -15.30M |
| Capital Expenditure | -578.00K | -560.00K | -563.00K | -48.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.42M | -26.98M | -23.88M | -21.42M | 758.00K |
| Cash from Investing | -32.00M | -27.54M | -24.45M | -21.46M | 742.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -774.00K | -957.00K | -1.13M | -689.00K | -695.00K |
| Issuance of Common Stock | 37.00M | 13.92M | 7.63M | 3.99M | 3.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66.82M | 78.87M | 58.24M | 52.49M | 5.95M |
| Cash from Financing | 103.05M | 91.82M | 64.73M | 55.80M | 8.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.83M | 42.68M | 21.66M | 17.08M | -5.63M |